Hunan Warrant Pharmaceutical Co., Ltd. Class ASSE: 688799

"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Changes in the Equity Structure of the Controlling Shareholder

Sep 28, 2026 · Issued by Hunan Warrant Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Changes in the Equity Structure of the Controlling Shareholder

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Hunan Warrant Pharmaceutical Co., Ltd. Class A

"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Change in Equity Interests of Controlling Shareholder and Its Persons Acting in Concert Reaching 1% Threshold and Result of Shareholding Reduction by Controlling Shareholder and Completion of Implementation of the Change in Shareholding Method by Controlling Shareholder's PartnerSep 19
"Hunan Warrant Pharmaceutical Co., Ltd."Indicative Announcement on Change in Equity Interests of the Controlling Shareholder and Its Person Acting in Concert Reaching 1% ThresholdSep 18
"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug IndustrySep 9
"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Voluntary Disclosure of the Subsidiary's Obtaining of the Approval Notice for Its API Marketing ApplicationSep 3

All Hunan Warrant Pharmaceutical Co., Ltd. Class A news releases